Latest Regulatory News

Credit Intelligence Ltd has announced a conditional agreement to sell its loss-making subsidiary Credit Intelligence Holding Limited for AUD 1.5 million, pending shareholder approval and regulatory clearances.

Helios Energy Limited has come under ASX compliance scrutiny after late lodgement of director interest notices, raising questions about its disclosure practices and governance.

Sky Metals has expanded the high-grade tin zone at its Tallebung project in NSW, reporting strong initial drilling results that have prompted a major increase in its exploration program.

Amplia Therapeutics reports strong progress in its pancreatic cancer drug development, completing the ACCENT trial recruitment ahead of schedule and initiating a new US trial, while managing a $6.57 million loss for FY25.

Mount Hope Mining Limited has announced a non-renounceable pro-rata Loyalty Option Offer to raise approximately $103,125, aiming to bolster exploration funding and reward shareholder loyalty.

RTG Mining has completed a A$15.3 million tranche 2 placement, bolstering its financial position to advance the Mabilo gold and copper project and explore new opportunities.

Horizon Minerals has acknowledged an unintentional breach of ASX Listing Rule 15.7 after sharing details of a $30 million placement with the media before the official market announcement.

Tempest Minerals has refined and extended the gold anomaly at its Sanity Prospect within the Yalgoo Project through denser geochemical sampling, boosting confidence in a potentially large mineralised system.

Cardiex Digital Vascular Biomarkers announces a A$6.5 million equity raise to fund inventory, marketing, product development, and debt repayment, aiming to solidify its position in the expanding cardiovascular health market.

Manuka Resources’ Taranaki VTM Project has advanced through a critical regulatory checkpoint, with no competing applications or appeals standing in its way, moving closer to expert panel determination.

Havilah Resources reports significant progress on its copper-gold-cobalt projects Kalkaroo and Mutooroo, alongside promising regional exploration and strategic funding efforts.

Little Green Pharma Ltd has reported a robust turnaround for FY2025, posting a $3.3 million profit after tax on revenues up 43%, driven by strong growth in Australia and Europe and strategic acquisitions.